Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001477932-21-004867
Filing Date
2021-07-23
Accepted
2021-07-23 16:04:54
Documents
6
Effectiveness Date
2021-07-23

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT vnrx_s8.htm S-8 80296
2 LEGAL OPINION AND CONSENT vnrx_ex51.htm EX-5.1 7840
3 AUDITOR'S CONSENT vnrx_ex232.htm EX-23.2 2508
4 vnrx_ex231img1.jpg GRAPHIC 2937
5 vnrx_ex231img2.jpg GRAPHIC 6063
6 vnrx_ex51img5.jpg GRAPHIC 6143
  Complete submission text file 0001477932-21-004867.txt   113037
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258133 | Film No.: 211110925
SIC: 2835 In Vitro & In Vivo Diagnostic Substances